Integrating omics and MRI data with kernel-based tests and CNNs to
  identify rare genetic markers for Alzheimer's disease
  For precision medicine and personalized treatment, we need to identify
predictive markers of disease. We focus on Alzheimer's disease (AD), where
magnetic resonance imaging scans provide information about the disease status.
By combining imaging with genome sequencing, we aim at identifying rare genetic
markers associated with quantitative traits predicted from convolutional neural
networks (CNNs), which traditionally have been derived manually by experts.
Kernel-based tests are a powerful tool for associating sets of genetic
variants, but how to optimally model rare genetic variants is still an open
research question. We propose a generalized set of kernels that incorporate
prior information from various annotations and multi-omics data. In the
analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI),
we evaluate whether (i) CNNs yield precise and reliable brain traits, and (ii)
the novel kernel-based tests can help to identify loci associated with AD. The
results indicate that CNNs provide a fast, scalable and precise tool to derive
quantitative AD traits and that new kernels integrating domain knowledge can
yield higher power in association tests of very rare variants.
